Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/11346336

Download in:

View as

General Info

PMID
11346336